Roche Products, Aspen Pharma, Merck Sharp & Dohme, Hospira, Pierre Fabre Medicament Australia, Sandoz, Fresenius Kabi Australia, Actavis, Alphapharm, Apotex, Dr Reddy's Laboratories, Generic Health
1 PBAC submission on file, first appeared 2014. 100% have been recommended.
Submissions
1
2014 → 2014
Win rate
100 %
1 recommended of 1 bucketable
Drugs
1 · 1 listed
unique molecules submitted
PBS spend captured
—
FY-latest govt benefit on owned drugs
Drug portfolio
Sorted by PBS spend captured. PBS expenditure is credited to the sponsor with the most recent Recommended decision per drug, so biosimilars and originator brands aren't double-counted.